Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for first-quarter profit on Thursday due to softer sales of its…

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von TD Cowen stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power are part of the Zacks top Analyst Blog.…

Todays Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Regeneron Pharmaceuticals, Inc. (REGN) and…

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential…

Charlotte (www.aktiencheck.de) - Rating-Update: Geoff Meacham, Analyst von BofA Securities, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Toronto (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Die kanadische Bank RBC Capital Markets stuft die Aktie von Regeneron Pharmaceuticals…

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) faced a blow in pre-market trading after being hit with fraud allegations from the US Justice…

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in…

Investors interested in the life science sector are well aware of the importance of biotechnology.From finding cures for diseases to…

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused…

The overall dynamics of the food allergy market are anticipated to change in the coming years owing to the expected…

Regeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by a significant 14...…

Kuehn Law investigates potential breach of fiduciary duties by Regeneron Pharmaceuticals officers and directors. Shareholders urged to contact for details.…

…

New York (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Morgan Stanley: Die Analysten von Morgan Stanley stufen die Aktie von Regeneron Pharmaceuticals Inc.…

…

New York (www.aktiencheck.de) - Rating-Update: William Pickering, Analyst von Sanford C. Bernstein & Co, nimmt die Coverage der Aktie von Regeneron…

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

…

Toronto (www.aktiencheck.de) - Rating-Update: Die Analysten von RBC Capital Markets stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…